Gene therapy developer Asklepios BioPharmaceutical (AskBio) has appointed Don Haut to serve as its chief business officer, the same position he held most recently at Sherlock Biosciences. His experience also includes business development roles at Histogenics, The Medicines Company, Smith & Nephew, and 3M (NYSE: [[ticker:MMM]]). Nearly a year ago, Research Triangle Park, NC-based AskBio raised $235 million to finance its gene therapy research and development work.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
